Madhya Pradesh High Court grants bail to two in Chhindwara toxic cough syrup case
Two medical representatives, arrested in connection with last year's deadly toxic cough syrup case in Chhindwara that claimed over 20 young lives, have been granted conditional bail by the Madhya Pradesh High Court. The accused, who claim no invol...

The government opposed their bail pleas, alleging that the two played a role in promoting the controversial cough syrup, managing its supply chain, and building a network of prescribing doctors. (File Photo)
A single bench of Justice Ajay Kumar Nirankari granted relief to the two accused on Tuesday, he said.
In their petition, Satish Verma and Shailesh Singh Pandya had submitted that they had no connection to the production of the toxic cough syrup, and as medical representatives, they had simply placed orders with the company for supplies and were unaware of any adulteration or defects in the medicine.
Read More: Government prescribes end to over-the-counter sale of cough syrups
Besides, they also had no role in the storage, distribution, or destruction of the drug, their petition said.
The police have completed the investigation and submitted relevant documents to the court. "The hearing of the case may take time. Applicants Satish Verma and Shailesh Singh Pandya have been in judicial custody since October 2025 and November 2025, respectively," said Sankalp Kochhar, who represented the duo.
However, the government opposed the bail applications, saying the two were accused of playing a role in the promotion of the controversial cough syrup, the supply chain and the development of a prescription network of doctors.
The applicants acted as the key link between the main accused Dr Praveen Soni, and the pharmaceutical company. The investigation has found significant evidence against the applicants, the prosecution said.
After hearing the applications, the single bench granted conditional bail to both the accused, Kochhar said.
In October 2025, children in Chhindwara district began falling ill after consuming Coldrif cough syrup, with complaints of vomiting, inability to urinate and fever.
Read More: mRNA vaccines protect against severe infectious diseases, review confirms
Investigations showed that the syrup contained diethylene glycol, a toxic chemical that causes kidney failure. The company owner and a government doctor, who allegedly recommended the syrup, were arrested in the case.
A sample of the syrup, tested by a government Drug Testing Laboratory in Chennai, was declared "Not of Standard Quality" by the Tamil Nadu Directorate of Drug Control, officials had said.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.